Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Queensland Health
McKinsey
Daiichi Sankyo
Julphar
Express Scripts
Moodys
Medtronic
Fish and Richardson
McKesson

Generated: January 16, 2018

DrugPatentWatch Database Preview

Clorazepate dipotassium - Generic Drug Details

« Back to Dashboard

What are the generic sources for clorazepate dipotassium and what is the scope of clorazepate dipotassium freedom to operate?

Clorazepate dipotassium
is the generic ingredient in four branded drugs marketed by Able, Am Therap, Aurolife Pharma Llc, Dava Pharms Inc, Gd Searle Llc, Mylan, Purepac Pharm, Quantum Pharmics, Usl Pharma, Warner Chilcott, Watson Labs, Recordati Rare, Lederle, Sun Pharm Inds Ltd, Taro Pharm, and Alra, and is included in sixty-two NDAs. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for clorazepate dipotassium. Nine suppliers are listed for this compound.
Pharmacology for clorazepate dipotassium
Ingredient-typeBenzodiazepines
Drug ClassBenzodiazepine
Medical Subject Heading (MeSH) Categories for clorazepate dipotassium

US Patents and Regulatory Information for clorazepate dipotassium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Taro Pharm CLORAZEPATE DIPOTASSIUM clorazepate dipotassium TABLET;ORAL 075731-002 Apr 27, 2000 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs CLORAZEPATE DIPOTASSIUM clorazepate dipotassium TABLET;ORAL 071852-001 Feb 9, 1988 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Aurolife Pharma Llc CLORAZEPATE DIPOTASSIUM clorazepate dipotassium CAPSULE;ORAL 072112-002 Aug 11, 2017 RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan CLORAZEPATE DIPOTASSIUM clorazepate dipotassium CAPSULE;ORAL 071509-001 Oct 19, 1987 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Recordati Rare TRANXENE clorazepate dipotassium TABLET;ORAL 017105-007 Approved Prior to Jan 1, 1982 AB RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Purepac Pharm CLORAZEPATE DIPOTASSIUM clorazepate dipotassium TABLET;ORAL 072330-001 Aug 8, 1988 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Recordati Rare TRANXENE SD clorazepate dipotassium TABLET;ORAL 017105-005 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Aurolife Pharma Llc CLORAZEPATE DIPOTASSIUM clorazepate dipotassium CAPSULE;ORAL 072112-001 Aug 26, 1988 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan CLORAZEPATE DIPOTASSIUM clorazepate dipotassium TABLET;ORAL 071858-003 Jul 17, 1987 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Able CLORAZEPATE DIPOTASSIUM clorazepate dipotassium TABLET;ORAL 071781-001 Jun 26, 1987 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for clorazepate dipotassium

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Recordati Rare TRANXENE clorazepate dipotassium TABLET;ORAL 017105-007 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Recordati Rare TRANXENE clorazepate dipotassium CAPSULE;ORAL 017105-001 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Recordati Rare TRANXENE SD clorazepate dipotassium TABLET;ORAL 017105-004 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Recordati Rare TRANXENE clorazepate dipotassium CAPSULE;ORAL 017105-002 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Recordati Rare TRANXENE clorazepate dipotassium TABLET;ORAL 017105-008 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Recordati Rare TRANXENE clorazepate dipotassium TABLET;ORAL 017105-006 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Recordati Rare TRANXENE clorazepate dipotassium CAPSULE;ORAL 017105-003 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Recordati Rare TRANXENE SD clorazepate dipotassium TABLET;ORAL 017105-005 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Dow
Federal Trade Commission
Cantor Fitzgerald
Citi
Julphar
Covington
UBS
Cerilliant
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot